[go: up one dir, main page]

FI903835A7 - Menetelmä farmaseuttisesti käyttökelpoisten 4-(N-substituoitu amino)-2-butynyyli-1-ureoiden ja -tioureoiden ja niiden johdannaisten valmistamiseksi - Google Patents

Menetelmä farmaseuttisesti käyttökelpoisten 4-(N-substituoitu amino)-2-butynyyli-1-ureoiden ja -tioureoiden ja niiden johdannaisten valmistamiseksi Download PDF

Info

Publication number
FI903835A7
FI903835A7 FI903835A FI903835A FI903835A7 FI 903835 A7 FI903835 A7 FI 903835A7 FI 903835 A FI903835 A FI 903835A FI 903835 A FI903835 A FI 903835A FI 903835 A7 FI903835 A7 FI 903835A7
Authority
FI
Finland
Prior art keywords
thioureas
ureas
butynyl
derivatives
preparation
Prior art date
Application number
FI903835A
Other languages
English (en)
Swedish (sv)
Other versions
FI903835A0 (fi
Inventor
Jeffrey Alan Kester
Walter Hamilton Moos
Anthony Jerome Thomas
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI903835A0 publication Critical patent/FI903835A0/fi
Publication of FI903835A7 publication Critical patent/FI903835A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/02Thiourea
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI903835A 1989-08-02 1990-08-01 Menetelmä farmaseuttisesti käyttökelpoisten 4-(N-substituoitu amino)-2-butynyyli-1-ureoiden ja -tioureoiden ja niiden johdannaisten valmistamiseksi FI903835A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/388,785 US4988688A (en) 1989-08-02 1989-08-02 4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents

Publications (2)

Publication Number Publication Date
FI903835A0 FI903835A0 (fi) 1990-08-01
FI903835A7 true FI903835A7 (fi) 1991-02-03

Family

ID=23535507

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903835A FI903835A7 (fi) 1989-08-02 1990-08-01 Menetelmä farmaseuttisesti käyttökelpoisten 4-(N-substituoitu amino)-2-butynyyli-1-ureoiden ja -tioureoiden ja niiden johdannaisten valmistamiseksi

Country Status (15)

Country Link
US (1) US4988688A (fi)
EP (1) EP0411615B1 (fi)
JP (1) JPH0374359A (fi)
KR (1) KR910004559A (fi)
AT (1) ATE99290T1 (fi)
AU (1) AU6001990A (fi)
CA (1) CA2022510A1 (fi)
DE (1) DE69005557T2 (fi)
DK (1) DK0411615T3 (fi)
ES (1) ES2062220T3 (fi)
FI (1) FI903835A7 (fi)
IE (1) IE902792A1 (fi)
NO (1) NO903384L (fi)
PT (1) PT94874A (fi)
ZA (1) ZA906057B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504278A (ja) * 1944-06-01 1997-04-28 ザ、ウェルカム、ファンデーション、リミテッド Noシンターゼインヒビターとしての置換尿素およびイソチオ尿素誘導体
US5202459A (en) * 1989-11-07 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for producing cyclobutane derivative
US5182284A (en) * 1990-01-26 1993-01-26 Taiho Pharmaceutical Co., Ltd. Piperazine compounds, processes for preparation thereof and medical uses thereof
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
US6090846A (en) * 1994-06-01 2000-07-18 Glaxo Wellcome Inc. Substituted urea and isothiourea derivatives as no synthase inhibitors
US6297276B1 (en) 1993-10-04 2001-10-02 Glaxosmithkline Substituted urea and isothiourea derivatives as no synthase inhibitors
US6225305B1 (en) 1993-10-04 2001-05-01 Glaxo Wellcome Inc. Substituted urea and isothiorea derivatives as no synthase inhibitors
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy
US6545182B2 (en) * 2000-04-13 2003-04-08 Allergan Sales, Inc. Methods and compositions for modulating alpha adrenergic receptor activity
US6313172B1 (en) * 2000-04-13 2001-11-06 Allergan Sales, Inc. Methods and compositions for modulating alpha adrenergic receptor activity
US7185522B2 (en) 2005-05-10 2007-03-06 T. Sendzimir, Inc. Side supported 6-high rolling mill

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065471A (en) * 1965-04-09 1977-12-27 Sterling Drug Inc. N-(4-Amino-2-butynyl)imides
US3354178A (en) * 1965-04-09 1967-11-21 Sterling Drug Inc Nu-(4-amino-2-butynyl)-nu-alkylcarboxamides

Also Published As

Publication number Publication date
ES2062220T3 (es) 1994-12-16
KR910004559A (ko) 1991-03-28
EP0411615B1 (en) 1993-12-29
US4988688A (en) 1991-01-29
JPH0374359A (ja) 1991-03-28
AU6001990A (en) 1991-02-07
NO903384D0 (no) 1990-08-01
EP0411615A1 (en) 1991-02-06
DK0411615T3 (da) 1994-01-24
IE902792A1 (en) 1991-02-27
ZA906057B (en) 1992-04-29
DE69005557T2 (de) 1994-04-21
FI903835A0 (fi) 1990-08-01
PT94874A (pt) 1991-04-18
NO903384L (no) 1991-02-04
DE69005557D1 (de) 1994-02-10
CA2022510A1 (en) 1991-02-03
ATE99290T1 (de) 1994-01-15

Similar Documents

Publication Publication Date Title
FI900085L (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(pyrimidin- ja kondensoitu pyrimidin-4-oni)etyyli-piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
FI905941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
FI905444A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
HU896032D0 (en) Process for the preparation of novel quinuc lidine derivatives and pharmaceutical compositions containing them
FI884966A7 (fi) 1-desoksinojirimysiinin ja 1-desoksimannonojirimysiinin N-substituoidut johdannaiset, menetelmä niiden valmistamiseki ja niiden käyttö lääkkeissä
PT84737B (pt) Processo para a preparacao de derivados de n-(2'-aminofenil)-benzamida e de composicoes farmaceuticas contendo-os
FI890072A7 (fi) Menetelmä farmaseuttisesti käyttökelpoisten isokinoliinijohdannaisten valmistamiseksi
FI953919A7 (fi) Pyrrolydeenimetyylijohdannaiset ja menetelmä niiden valmistamiseksi
FI905748A7 (fi) Menetelmä dopamiinin ja dopamiinijohdannaisten 4-O-fosfaattien valmis tamiseksi
FI906408L (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi
FI903835A7 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 4-(N-substituoitu amino)-2-butynyyli-1-ureoiden ja -tioureoiden ja niiden johdannaisten valmistamiseksi
FI944713L (fi) 4-difenyylimetyylipiperidiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI904838A7 (fi) Menetelmä farmaseuttisesti aktiivisten karboksitetrahydroisokinoliinien ja niiden johdannaisten valmistamiseksi
FI894604L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridyyli- ja pyrimidyylipiperatsiinijohdannaisten valmistamiseksi
FI891123A7 (fi) Menetelmä 1-syklopropyylikinolonikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
HU896612D0 (en) Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof
HU896479D0 (en) Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof
FI894546A7 (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
FI903834A7 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 4-(N-substituoitu amino)-2-butynyyli-1-karbamaattien ja -tiokarbamaattien ja niiden johdannaisten valmistamiseksi
FI922343A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperidiini- ja pyrrolidiinijohdannaisten valmistamiseksi
PT87024A (pt) Process for the preparation of propiolophenone derivatives and of pharmaceutical compositions containing the same
PT87550A (pt) Process for the preparation of pyrimidine derivatives and of pharmaceutical compositions containing the same
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
FI920566L (fi) Menetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinien ja niiden johdannaisten valmistamiseksi
PT86925A (pt) Process for the preparation of imidazodiazepine derivatives and of pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: WARNER-LAMBERT COMPANY